Erschienen in:
26.02.2020 | What's New in Intensive Care
What’s new in cardiogenic shock?
verfasst von:
Marc Pineton de Chambrun, Dirk W. Donker, Alain Combes
Erschienen in:
Intensive Care Medicine
|
Ausgabe 5/2020
Einloggen, um Zugang zu erhalten
Excerpt
Cardiogenic shock (CS) is defined as primary cardiac dysfunction leading to critical organ hypoperfusion and hypoxemia. Diagnostic criteria include persistent hypotension and signs of compromised end-organ perfusion such as cold extremities, oliguria or altered mental status despite correction of underlying hypovolemia [
1]. Acute myocardial infarction (AMI) is the most frequent cause of CS, representing up to 70% of cases and occurring in 5–10% of patients with AMI. Despite major therapeutic advances, mortality of CS in the setting of AMI remained unacceptably high (40–50%) in recent years [
2]. Since the proportion of patients admitted to intensive care units with CS has increased in recent years, intensivists should benefit from the latest information on the care of this high-risk population [
3]. …